#Goldman sachs wire instruction series#

Plus, in the case of the floating rate notes, interest deemed to have accrued from JuneВ 7, 2019 to, butД®xcluding, the settlement date totaling ВЂ. The prices to investors set forth above do not include accrued interest, if any. S-18 of this prospectus supplement, as well as the documents we file with the Securities and Exchange Commission that are incorporated by reference herein for more information. The New York StockД®xchange is not a regulated market for the purposes of the EU Directive on Markets in Financial Instruments (2014/65/EU) (as amended, В“MiFID IIВ”). Upon such listing, Medtronic Luxco will use commercially reasonable efforts to maintain such listing and satisfy the requirements for such continued listing as long as the notes are outstanding. The listing application will be subject to approval by the Medtronic Luxco intends to apply to list the notes on the New York Stock Exchange. The guarantees will rank equally in right of payment with all of Medtronic plcВ’s and Medtronic, Inc.В’s other existing and future unsecured senior Subsidiary of Medtronic Luxco, on a senior unsecured basis (the В“guaranteesВ”). Medtronic LuxcoВ’s obligations under the notes will be fully and unconditionally guaranteed by Medtronic Public Limited Company (В“Medtronic plcВ”), Medtronic LuxcoВ’s parent, and by Medtronic, Inc., a wholly-owned indirect Medtronic Luxco and will rank equally in right of payment with all of Medtronic LuxcoВ’s other existing and future unsecured senior obligations and will rank senior to any subordinated indebtedness that Medtronic Luxco may incur. The notes will be general unsecured senior obligations of S.C.A.В—Redemption Upon Changes in Withholding TaxesВ” in the accompanying prospectus. See в€Ѕescription of Debt Securities of Medtronic Global Holdings

#Goldman sachs wire instruction series#

The notes of any series may be redeemed in whole but not in part, at any time at our option, in the event of certain developments affecting U.S., Luxembourg or Irish taxation. Notes may be redeemed, in whole or in part, at any time prior to their maturity at the applicable redemption prices described in this prospectus supplement under the heading, в€Ѕescription of NotesВ—Optional Redemption.В” In addition, The floating rate notes are not redeemable prior to their maturity except in connection with certain tax events as described in this paragraph. Upon settlement, the floating rate notes will have the same CUSIP number and will trade interchangeably with the existing floating rate notes. Terms, other than the initial offering price, as the existing floating rate notes. The floating rate notes offered hereby constitute aДЇurther issuance of the Floating Rate Senior Notes due 2021, of which ВЂ500,000,000 aggregate principal amount was issued on MarchВ 7, 2019 (the В“existing floating rate notesВ”) and will form a single series with, and have the same Interest will be paid on the fixed rate notes on of each year, beginning on Interest will be paid on the floating rate notes on MarchВ 7, JuneВ 7, SeptemberВ 7 and DecemberВ 7 ofД®ach year, beginning on SeptemberВ 7, 2019. , 2031, the 2039 notes will mature on, 2039 and theДў049 notes will mature on, 2049. The 2022 notes will mature on, 2022, theДў025 notes will mature on, 2025, the 2031 notes will mature on Referred to collectively as the В“notes.В” The floating rate notes will mature on MarchВ 7, 2021. The floating rate notes and the fixed rate notes are % senior notes due 2049 (the в€І049 notesВ” and together with the 2022 notes, the 2025 notes, the 2031 notes and the 2039 notes, the В“fixed rate notesВ”). % senior notes due 2025 (the в€І025 notesВ”), ВЂ aggregate principal amount of % senior notes due 2031 (the в€І031 notesВ”), ВЂДЄggregate principal amount of % senior notes due 2039 (the в€І039 notesВ”) and ВЂ aggregate principal amount of (В“Medtronic LuxcoВ”) is offering ВЂ aggregate principal amount of floating rate senior notes due 2021 (ISIN: XS1960675822) (the В“floating rate notesВ”), ВЂДЄggregate principal amount of % senior notes due 2022 (the в€І022 notesВ”), ВЂ aggregate principal amount of MEDTRONIC PUBLIC LIMITED COMPANY and MEDTRONIC, INC. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and we are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is The information in this preliminary prospectus supplement is notД¬omplete and may be changed.